1997
DOI: 10.1097/00132586-199712000-00060
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Diuretic-Based Antihypertensive Treatment on Cardiovascular Disease Risk in Older Diabetic Patients with Isolated Systolic Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
103
0
2

Year Published

1998
1998
2010
2010

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 80 publications
(110 citation statements)
references
References 0 publications
5
103
0
2
Order By: Relevance
“…12 Less clear is why the relative risk of DM as a CVD risk factor has not changed. Clinical trial data for CVD risk factor control suggest that individuals with DM have higher absolute reductions in CVD outcomes than nondiabetic individuals when treated for hypertension 26 and dyslipidemia. 27,28 However, in the setting of acute coronary syndrome, individuals with DM fare worse than individuals without DM.…”
Section: Discussionmentioning
confidence: 99%
“…12 Less clear is why the relative risk of DM as a CVD risk factor has not changed. Clinical trial data for CVD risk factor control suggest that individuals with DM have higher absolute reductions in CVD outcomes than nondiabetic individuals when treated for hypertension 26 and dyslipidemia. 27,28 However, in the setting of acute coronary syndrome, individuals with DM fare worse than individuals without DM.…”
Section: Discussionmentioning
confidence: 99%
“…30 Results from the Systolic Hypertension in the Elderly Patient (SHEP) study have shown that chlorthalidone therapy (doses 12.5 to 25 mg) was twice as effective in preventing cardiovascular events in diabetics than in nondiabetic hypertensive patients. 31 In clinical practice, it is almost impossible to control blood pressure in diabetic patients without the use of diuretics. Most frequently, thiazides have to be replaced by more potent loop diuretics to control blood pressure, especially when renal damage progresses.…”
Section: Diureticsmentioning
confidence: 99%
“…There is strong evidence from clinical trials of the value of treating hypertension in the elderly (269). There is less evidence for lipid-lowering and aspirin therapy, although the benefits of these interventions for primary and secondary prevention are likely to apply to older adults whose life expectancies equal or exceed the timeframes seen in clinical trials.…”
Section: Older Adults Recommendationsmentioning
confidence: 99%